校正:一种口服的M细胞向乳球菌乳球菌疫苗,用于对抗 Echinococcus multilocularis 感染
Yang Xiao1,2, Zhao-Hui Luo3, Shun-Juan Wang4
1Research Center for High Altitude Medicine, Qinghai University, Xining, Qinghai, China.
Frontiers in immunology
|December 5, 2025
概括
这项研究纠正了先前发表的一篇文章. 校正确保了准确的引用,用于该领域的未来研究.
科学领域:
- 免疫学 免疫学 免疫学
- 科学出版科学出版
背景情况:
- 以前的出版物中包含了一个不正确的文章标识符.
- 准确的DOI对于科学文献跟踪至关重要.
研究的目的:
- 为特定出版物提供正确的文章DOI.
- 确保科学记录的完整性.
主要方法:
- 纠正数字对象标识符 (DOI).
主要成果:
- 这篇文章的DOI已经更新到10.3389/fimmu.2025.1683003.3.
- 确保科学工作的准确引用和检索.
结论:
- 校正方便了正确的引用和对研究的访问.
- 保持准确的元数据对于科学沟通至关重要.
相关概念视频
Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Bacterial Gastroenteritis
88
Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
88


